Thomas Bowhay
Family Medicine · Jackson, CANPI 1902919665
Payments from drug & device makers
Across 215 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- GSK$390
- Novo Nordisk$314
- AstraZeneca$271
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$206
- Medtronic$175
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,478100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $844 |
| GSK | 24 | $390 |
| Novo Nordisk | 15 | $314 |
| AstraZeneca | 17 | $271 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $206 |
| Medtronic | 1 | $175 |
| Forte Bio-pharma LLC | 3 | $173 |
| Ultragenyx Pharmaceutical Inc. | 6 | $126 |
| Eisai Inc. | 7 | $122 |
| Boehringer Ingelheim | 8 | $118 |
| Pfizer | 7 | $105 |
| Biohaven Pharmaceuticals, Inc. | 5 | $82 |
| Idorsia Pharmaceuticals US Inc | 5 | $77 |
| Bayer | 3 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Sunovion Pharmaceuticals Inc. | 3 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $46 |
| Merck | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Novartis | 1 | $22 |
| Amgen | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Indivior Inc. | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolate$346
- Reveal LINQ$175
- Nalocet$115
How this compares
$3,478 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $31,565 |
| SynthroidLevothyroxine Sodium | 11 | $1,121 |
| Tamsulosin Hcl | 58 | $1,082 |
| Rosuvastatin Calcium | 30 | $679 |
| Atorvastatin Calcium | 67 | $673 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $506 |
| Amlodipine Besylate | 63 | $459 |
| Metoprolol Succinate | 36 | $444 |
| Pantoprazole Sodium | 42 | $442 |
| Levothyroxine Sodium | 40 | $440 |
| Potassium Chloride | 15 | $415 |
| Lisinopril | 58 | $393 |
| Furosemide | 48 | $329 |
| Gabapentin | 19 | $292 |
| Digoxin | 17 | $290 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $105 | $31,56531 claims |
| AbbVieSynthroid | $844 | $1,12111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,533 family medicine providers in California.
Other family medicine in Jackson
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.